Celyad’s CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer

Celyad’s CAR T-cell Therapy Shows Promise in 2 Patients with Advanced Colorectal Cancer
New data from the Phase 1 THINK clinical trial (NCT03018405) show that two metastatic colorectal cancer (mCRC) patients whose disease progressed following at least two prior therapies had stabilized the disease at a three-month follow-up after receiving the lowest dose level of Celyad’s NKR-2 CAR T-cell therapy. The third person included in the dose cohort, a

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

  1. anu bajaj says:

    My mom in law is dignosed by fourth stage overian cancer.surgery followed by two chemotherapy ,radiotherapy all had done till date..but its still spreading and now internal bleeding is there..can this T Cell treatment do sumthing to cure her? Kindly revert.

  2. Jeannine kelsey says:

    My husband is stage4 rectal cancer. Appears now in bilateral lungs and adrenal gland. All tumors are relatively small. We have prayed for him to live long enough for a better treatment. This sounds like our answer. As a father of 7 we NEED him here. Who can we talk to about this treatment option?

Leave a Comment

Your email address will not be published. Required fields are marked *